Literature DB >> 21367891

Second-site compensatory mutations of HIV-1 capsid mutations.

Colleen M Noviello1, Claudia S López, Ben Kukull, Henry McNett, Amelia Still, Jacob Eccles, Rachel Sloan, Eric Barklis.   

Abstract

The human immunodeficiency virus (HIV) capsid (CA) protein assembles into a hexameric lattice that forms the mature virus core. Contacts between the CA N-terminal domain (NTD) of one monomer and the C-terminal domain (CTD) of the adjacent monomer are important for the assembly of this core. In this study, we have examined the effects of mutations in the NTD region associated with this interaction. We have found that such mutations yielded modest reductions of virus release but major effects on viral infectivity. Cell culture and in vitro assays indicate that the infectivity defects relate to abnormalities in the viral cores. We have selected second-site compensatory mutations that partially restored HIV infectivity. These mutations map to the CA CTD and to spacer peptide 1 (SP1), the portion of the precursor Gag protein immediately C terminal to the CTD. The compensatory mutations do not locate to the molecularly modeled intermolecular NTD-CTD interface. Rather, the compensatory mutations appear to act indirectly, possibly by realignment of the C-terminal helix of the CA CTD, which participates in the NTD-CTD interface and has been shown to serve an important role in the assembly of infectious virus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367891      PMCID: PMC3126181          DOI: 10.1128/JVI.00099-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

2.  Structure and assembly of immature HIV.

Authors:  J A G Briggs; J D Riches; B Glass; V Bartonova; G Zanetti; H-G Kräusslich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

3.  The role of nucleocapsid of HIV-1 in virus assembly.

Authors:  L Dawson; X F Yu
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

4.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

5.  Characterization of the in vitro HIV-1 capsid assembly pathway.

Authors:  Eric Barklis; Ayna Alfadhli; Carolyn McQuaw; Suraj Yalamuri; Amelia Still; Robin Lid Barklis; Ben Kukull; Claudia S López
Journal:  J Mol Biol       Date:  2009-02-03       Impact factor: 5.469

6.  Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.

Authors:  Vineela Chukkapalli; Ian B Hogue; Vitaly Boyko; Wei-Shau Hu; Akira Ono
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate.

Authors:  Ayna Alfadhli; Robin Lid Barklis; Eric Barklis
Journal:  Virology       Date:  2009-03-27       Impact factor: 3.616

8.  Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function.

Authors:  In-Ja L Byeon; Xin Meng; Jinwon Jung; Gongpu Zhao; Ruifeng Yang; Jinwoo Ahn; Jiong Shi; Jason Concel; Christopher Aiken; Peijun Zhang; Angela M Gronenborn
Journal:  Cell       Date:  2009-11-13       Impact factor: 41.582

9.  X-ray structures of the hexameric building block of the HIV capsid.

Authors:  Owen Pornillos; Barbie K Ganser-Pornillos; Brian N Kelly; Yuanzi Hua; Frank G Whitby; C David Stout; Wesley I Sundquist; Christopher P Hill; Mark Yeager
Journal:  Cell       Date:  2009-06-11       Impact factor: 41.582

10.  Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.

Authors:  Natalia Ristic; Mario P S Chin
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

View more
  27 in total

1.  Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.

Authors:  Sandhya Kortagere; Navid Madani; Marie K Mankowski; Arne Schön; Isaac Zentner; Gokul Swaminathan; Amy Princiotto; Kevin Anthony; Apara Oza; Luz-Jeannette Sierra; Shendra R Passic; Xiaozhao Wang; David M Jones; Eric Stavale; Fred C Krebs; Julio Martín-García; Ernesto Freire; Roger G Ptak; Joseph Sodroski; Simon Cocklin; Amos B Smith
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

Authors:  Christopher Ritchie; Isabel Cylinder; Emily J Platt; Eric Barklis
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

3.  Authentication Analysis of MT-4 Cells Distributed by the National Institutes of Health AIDS Reagent Program.

Authors:  Melissa V Fernandez; Krista A Delviks-Frankenberry; David A Scheiblin; Christine Happel; Vinay K Pathak; Eric O Freed
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  Potential role for CA-SP in nucleating retroviral capsid maturation.

Authors:  Matthew R England; John G Purdy; Ira J Ropson; Paula M Dalessio; Rebecca C Craven
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

5.  Genome-Wide Mutagenesis of Hepatitis C Virus Reveals Ability of Genome To Overcome Detrimental Mutations.

Authors:  Deepak Singh; Shalini Soni; Shaheen Khan; Aditya N Sarangi; Ragothaman M Yennamalli; Rakesh Aggarwal; Naga Suresh Veerapu
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

6.  Rescue of deleterious mutations by the compensatory Y30F mutation in ketosteroid isomerase.

Authors:  Hyung Jin Cha; Do Soo Jang; Yeon-Gil Kim; Bee Hak Hong; Jae-Sung Woo; Kyong-Tai Kim; Kwan Yong Choi
Journal:  Mol Cells       Date:  2013-06-03       Impact factor: 5.034

7.  Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

Authors:  Ayna Alfadhli; Andrew Mack; Logan Harper; Sam Berk; Christopher Ritchie; Eric Barklis
Journal:  Bioorg Med Chem       Date:  2016-09-12       Impact factor: 3.641

Review 8.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

Authors:  Zandrea Ambrose; Christopher Aiken
Journal:  Virology       Date:  2014-02-20       Impact factor: 3.616

9.  Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein.

Authors:  Claudia S López; Seyram M Tsagli; Rachel Sloan; Jacob Eccles; Eric Barklis
Journal:  Virology       Date:  2013-09-21       Impact factor: 3.616

10.  Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.

Authors:  Melissa V Fernandez; Huxley K Hoffman; Nairi Pezeshkian; Philip R Tedbury; Schuyler B van Engelenburg; Eric O Freed
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.